Systematic review of 21 trials (1242 participants) in follicular lymphoma progressing within 24 months: pooled CAR T-cell therapy showed ORR 91.2% and CR 75.7%, the highest CR; bispecific antibodies showed ORR 81.6% and CR 65.7%.
Meta-analysisn = 1,242
Shen et al. Treatment and survival outcomes for patients with follicular lymphoma and POD24: a systematic review and meta-analysis